For the year ending 2025-12-31, ENZN had -$4,285K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | -3,409 |
| Deferred income taxes | 17 |
| Decrease in other current assets | -54 |
| Increase (decrease) in accrued expenses and other current liabilities | 328 |
| Net cash (used in) provided by operating activities | -3,010 |
| Preferred stock dividend payments | 1,275 |
| Net cash used in financing activities | -1,275 |
| Net decrease in cash | -4,285 |
| Cash and cash equivalents at beginning of year | 46,859 |
| Cash and cash equivalents at end of year | 42,574 |
ENZON PHARMACEUTICALS, INC. (ENZN)
ENZON PHARMACEUTICALS, INC. (ENZN)